Racetam

A family of synthetic compounds sharing a pyrrolidone backbone — the original modern nootropic class, descended from Giurgea’s 1964 synthesis of piracetam.

Why it matters

Racetams share a structural core (a five-membered lactam ring) but differ in side groups and pharmacology. The major members are piracetam, aniracetam, oxiracetam, pramiracetam, phenylpiracetam, and noopept (technically a peptide but functionally similar). Their proposed mechanisms include AMPA receptor modulation, cholinergic facilitation, and increased neuronal metabolism — though the evidence for cognitive enhancement in healthy adults is modest.

In practice

For consumers, racetams are most often paired with a choline source (alpha-GPC, CDP-choline) to offset reports of acetylcholine depletion at higher doses. Regulatory status varies: piracetam is unscheduled in the US but not approved for any indication, restricting marketing claims.

Common confusion

Racetams are sometimes pitched as “smart drugs.” The effect in cognitively healthy adults is typically subtle and inconsistent.

This glossary entry is editorial content reviewed against primary sources. It is not medical advice. See our Editorial Policy.